228 related articles for article (PubMed ID: 19157421)
1. NNZ-2566: a Gly-Pro-Glu analogue with neuroprotective efficacy in a rat model of acute focal stroke.
Bickerdike MJ; Thomas GB; Batchelor DC; Sirimanne ES; Leong W; Lin H; Sieg F; Wen J; Brimble MA; Harris PW; Gluckman PD
J Neurol Sci; 2009 Mar; 278(1-2):85-90. PubMed ID: 19157421
[TBL] [Abstract][Full Text] [Related]
2. SB 234551 selective ET(A) receptor antagonism: perfusion/diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection.
Legos JJ; Lenhard SC; Haimbach RE; Schaeffer TR; Bentley RG; McVey MJ; Chandra S; Irving EA; Andrew A Parsons ; Barone FC
Exp Neurol; 2008 Jul; 212(1):53-62. PubMed ID: 18462720
[TBL] [Abstract][Full Text] [Related]
3. NNZ-2566, a glypromate analog, improves functional recovery and attenuates apoptosis and inflammation in a rat model of penetrating ballistic-type brain injury.
Lu XC; Chen RW; Yao C; Wei H; Yang X; Liao Z; Dave JR; Tortella FC
J Neurotrauma; 2009 Jan; 26(1):141-54. PubMed ID: 19119917
[TBL] [Abstract][Full Text] [Related]
4. Peripheral administration of a novel diketopiperazine, NNZ 2591, prevents brain injury and improves somatosensory-motor function following hypoxia-ischemia in adult rats.
Guan J; Mathai S; Harris P; Wen JY; Zhang R; Brimble M; Gluckman P
Neuropharmacology; 2007 Nov; 53(6):749-62. PubMed ID: 17904590
[TBL] [Abstract][Full Text] [Related]
5. NNZ-2566, a glypromate analog, attenuates brain ischemia-induced non-convulsive seizures in rats.
Lu XC; Si Y; Williams AJ; Hartings JA; Gryder D; Tortella FC
J Cereb Blood Flow Metab; 2009 Dec; 29(12):1924-32. PubMed ID: 19638995
[TBL] [Abstract][Full Text] [Related]
6. Neuroprotective effects of the N-terminal tripeptide of insulin-like growth factor-1, glycine-proline-glutamate (GPE) following intravenous infusion in hypoxic-ischemic adult rats.
Guan J; Thomas GB; Lin H; Mathai S; Bachelor DC; George S; Gluckman PD
Neuropharmacology; 2004 Nov; 47(6):892-903. PubMed ID: 15527823
[TBL] [Abstract][Full Text] [Related]
7. Neuroprotective effects of KCL-440, a new poly(ADP-ribose) polymerase inhibitor, in the rat middle cerebral artery occlusion model.
Ikeda Y; Hokamura K; Kawai T; Ishiyama J; Ishikawa K; Anraku T; Uno T; Umemura K
Brain Res; 2005 Oct; 1060(1-2):73-80. PubMed ID: 16202986
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotective effects of a standardized extract of Diospyros kaki leaves on MCAO transient focal cerebral ischemic rats and cultured neurons injured by glutamate or hypoxia.
Bei W; Peng W; Zang L; Xie Z; Hu D; Xu A
Planta Med; 2007 Jun; 73(7):636-43. PubMed ID: 17583826
[TBL] [Abstract][Full Text] [Related]
9. Delayed peripheral administration of a GPE analogue induces astrogliosis and angiogenesis and reduces inflammation and brain injury following hypoxia-ischemia in the neonatal rat.
Svedin P; Guan J; Mathai S; Zhang R; Wang X; Gustavsson M; Hagberg H; Mallard C
Dev Neurosci; 2007; 29(4-5):393-402. PubMed ID: 17762207
[TBL] [Abstract][Full Text] [Related]
10. Delayed post ischemic treatment with Rosiglitazone attenuates infarct volume, neurological deficits and neutrophilia after embolic stroke in rat.
Allahtavakoli M; Moloudi R; Arababadi MK; Shamsizadeh A; Javanmardi K
Brain Res; 2009 May; 1271():121-7. PubMed ID: 19332033
[TBL] [Abstract][Full Text] [Related]
11. Glial growth factor 2 promotes functional recovery with treatment initiated up to 7 days after permanent focal ischemic stroke.
Iaci JF; Ganguly A; Finklestein SP; Parry TJ; Ren J; Saha S; Sietsma DK; Srinivas M; Vecchione AM; Caggiano AO
Neuropharmacology; 2010 Dec; 59(7-8):640-9. PubMed ID: 20691195
[TBL] [Abstract][Full Text] [Related]
12. Neuroprotective efficacy of repinotan HCl, a 5-HT1A receptor agonist, in animal models of stroke and traumatic brain injury.
Mauler F; Horváth E
J Cereb Blood Flow Metab; 2005 Apr; 25(4):451-9. PubMed ID: 15674237
[TBL] [Abstract][Full Text] [Related]
13. Tanshinone IIB, a primary active constituent from Salvia miltiorrhza, exhibits neuro-protective activity in experimentally stroked rats.
Yu XY; Lin SG; Zhou ZW; Chen X; Liang J; Duan W; Yu XQ; Wen JY; Chowbay B; Li CG; Sheu FS; Chan E; Zhou SF
Neurosci Lett; 2007 May; 417(3):261-5. PubMed ID: 17397998
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo neuroprotective effect and mechanisms of glabridin, a major active isoflavan from Glycyrrhiza glabra (licorice).
Yu XQ; Xue CC; Zhou ZW; Li CG; Du YM; Liang J; Zhou SF
Life Sci; 2008 Jan; 82(1-2):68-78. PubMed ID: 18048062
[TBL] [Abstract][Full Text] [Related]
15. Stilbazulenyl nitrone, a novel antioxidant, is highly neuroprotective in focal ischemia.
Ginsberg MD; Becker DA; Busto R; Belayev A; Zhang Y; Khoutorova L; Ley JJ; Zhao W; Belayev L
Ann Neurol; 2003 Sep; 54(3):330-42. PubMed ID: 12953265
[TBL] [Abstract][Full Text] [Related]
16. GIF-0173 protects against cerebral infarction through DP1 receptor activation.
Thura M; Hokamura K; Yamamoto S; Maeda M; Furuta K; Suzuki M; Ibaraki K; Umemura K
Exp Neurol; 2009 Oct; 219(2):481-91. PubMed ID: 19576888
[TBL] [Abstract][Full Text] [Related]
17. Effects of the PDE5-inhibitor vardenafil in a mouse stroke model.
Royl G; Balkaya M; Lehmann S; Lehnardt S; Stohlmann K; Lindauer U; Endres M; Dirnagl U; Meisel A
Brain Res; 2009 Apr; 1265():148-57. PubMed ID: 19368809
[TBL] [Abstract][Full Text] [Related]
18. Thalidomide protects against ischemic neuronal damage induced by focal cerebral ischemia in mice.
Hyakkoku K; Nakajima Y; Izuta H; Shimazawa M; Yamamoto T; Shibata N; Hara H
Neuroscience; 2009 Mar; 159(2):760-9. PubMed ID: 19166916
[TBL] [Abstract][Full Text] [Related]
19. Cerebral protection of purified Herba Leonuri extract on middle cerebral artery occluded rats.
Loh KP; Huang SH; Tan BK; Zhu YZ
J Ethnopharmacol; 2009 Sep; 125(2):337-43. PubMed ID: 19497358
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotective profile of novel SRC kinase inhibitors in rodent models of cerebral ischemia.
Liang S; Pong K; Gonzales C; Chen Y; Ling HP; Mark RJ; Boschelli F; Boschelli DH; Ye F; Barrios Sosa AC; Mansour TS; Frost P; Wood A; Pangalos MN; Zaleska MM
J Pharmacol Exp Ther; 2009 Dec; 331(3):827-35. PubMed ID: 19741150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
